Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00558402 · ClinicalTrials.gov registry record · Phase 2
Meditation or Education for Alzheimer Caregivers
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT00558402 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 72 participants.
The verdict
NCT00558402, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The goal is to determine how 6-week stress reduction techniques may decrease stress in primary caregivers of people with Alzheimer's disease. The 3 intervention programs are meditation, education, and respite care. There will be approximately 108 subjects over 3 years. Subjects will have a screening session over the phone to see if they are eligible (50-85 years old, spending at least 12 hours per week caring for a close relative with Alzheimer's disease, willing to be in any of the 3 groups, and without any very serious medical problem). The subjects will have 3 testing sessions, 1 before classes/respite and 2 after classes are over, each lasting about 3 hours. The classes are taught in a one-on-one setting, and they are 50 minutes per week for 6 weeks. Respite care is provided for the person with Alzheimer's disease in all the groups. Measurements include people's ratings of stress, psychological testing, and biological measurements of stress, including the following: saliva, blood, and urine collection; waist-to-hip ratio; weight; blood pressure; heart rate; respiration; reaction time task; voice recordings; electrocardiogram; electroencephalogram; and electro dermal activity.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Meditation
- BEHAVIORAL Respite only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00558402
The ClinicalTrials.gov registry entry for NCT00558402 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Education is the first listed.
NCT00558402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00558402 about?
NCT00558402 is a clinical study titled "Meditation or Education for Alzheimer Caregivers". The goal is to determine how 6-week stress reduction techniques may decrease stress in primary caregivers of people with Alzheimer's disease. The 3 intervention programs are meditation, education, and respite care. There will be approximately 108 subjects over 3 years. Subjects will have a screening...
What is the current status of trial NCT00558402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2007-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00558402?
The interventions under investigation include: Education (BEHAVIORAL), Meditation (BEHAVIORAL), Respite only (BEHAVIORAL).
Who is sponsoring clinical trial NCT00558402?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.